Literature DB >> 17675505

Despite increased CD4+Foxp3+ cells within the infection site, BALB/c IL-4 receptor-deficient mice reveal CD4+Foxp3-negative T cells as a source of IL-10 in Leishmania major susceptibility.

Hisashi Nagase1, Kathryn M Jones, Charles F Anderson, Nancy Noben-Trauth.   

Abstract

BALB/c IL-4Ralpha(-/-) mice, despite the absence of IL-4/IL-13 signaling and potent Th2 responses, remain highly susceptible to Leishmania major substain LV39 due exclusively to residual levels of IL-10. To address the contribution of CD4(+)CD25(+) T regulatory (Treg) cells to IL-10-mediated susceptibility, we depleted CD4(+)CD25(+) cells in vivo and reconstituted IL-4Ralpha x RAG2 recipients with purified CD4(+)CD25(-) T cells. Although anti-CD25 mAb treatment significantly decreased parasite numbers in IL-4Ralpha(-/-) mice, treatment with anti-IL-10R mAb virtually eliminated L. major parasites in both footpad and dermal infection sites. In addition, IL-4Ralpha x RAG2 mice reconstituted with CD4(+) cells depleted of CD25(+) Treg cells remained highly susceptible to infection. Analysis of L. major-infected BALB/c and IL-4Ralpha(-/-) inflammatory sites revealed that the majority of IL-10 was secreted by the CD4(+)Foxp3(-) population, with a fraction of IL-10 coming from CD4(+)Foxp3(+) Treg cells. All T cell IFN-gamma production was also derived from the CD4(+)Foxp3(-) population. Nevertheless, the IL-4Ralpha(-/-)-infected ear dermis, but not draining lymph nodes, consistently displayed 1.5- to 2-fold greater percentages of CD4(+)CD25(+) and CD4(+)Foxp3(+) Treg cells compared with the BALB/c-infected dermis. Thus, CD4(+)Foxp3(-) T cells are a major source of IL-10 that disrupts IFN-gamma activity in L. major-susceptible BALB/c mice. However, the increase in CD4(+)Foxp3(+) T cells within the IL-4Ralpha(-/-) dermis implies a possible IL-10-independent role for Treg cells within the infection site, and may indicate a novel immune escape mechanism used by L. major parasites in the absence of IL-4/IL-13 signaling.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17675505     DOI: 10.4049/jimmunol.179.4.2435

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  19 in total

Review 1.  Regulation of immunity at tissue sites of inflammation.

Authors:  Dorothy K Sojka; Christopher A Lazarski; Yu-Hui Huang; Irina Bromberg; Angela Hughson; Deborah J Fowell
Journal:  Immunol Res       Date:  2009-01-31       Impact factor: 2.829

2.  Accelerated healing of cutaneous leishmaniasis in non-healing BALB/c mice using water soluble amphotericin B-polymethacrylic acid.

Authors:  Karina Corware; Debra Harris; Ian Teo; Matthew Rogers; Kikkeri Naresh; Ingrid Müller; Sunil Shaunak
Journal:  Biomaterials       Date:  2011-07-31       Impact factor: 12.479

3.  Role of TLR2-dependent IL-10 production in the inhibition of the initial IFN-γ T cell response to Porphyromonas gingivalis.

Authors:  Dalia E Gaddis; Craig L Maynard; Casey T Weaver; Suzanne M Michalek; Jannet Katz
Journal:  J Leukoc Biol       Date:  2012-10-17       Impact factor: 4.962

4.  Tr-1-like CD4+CD25-CD127-/lowFOXP3- cells are the main source of interleukin 10 in patients with cutaneous leishmaniasis due to Leishmania braziliensis.

Authors:  Diego L Costa; Tiago M Cardoso; Adriano Queiroz; Cristiane M Milanezi; Olívia Bacellar; Edgar M Carvalho; João S Silva
Journal:  J Infect Dis       Date:  2014-08-19       Impact factor: 5.226

5.  Treatment with IP-10 induces host-protective immune response by regulating the T regulatory cell functioning in Leishmania donovani-infected mice.

Authors:  Gaurav Gupta; Saikat Majumdar; Anupam Adhikari; Parna Bhattacharya; Asok Kumar Mukherjee; Suchandra Bhattacharyya Majumdar; Subrata Majumdar
Journal:  Med Microbiol Immunol       Date:  2011-05-01       Impact factor: 3.402

6.  Aberrant host defense against Leishmania major in the absence of SLPI.

Authors:  Nancy McCartney-Francis; Wenwen Jin; Yasmine Belkaid; George McGrady; Sharon M Wahl
Journal:  J Leukoc Biol       Date:  2014-07-16       Impact factor: 4.962

7.  Intralesional regulatory T-cell suppressive function during human acute and chronic cutaneous leishmaniasis due to Leishmania guyanensis.

Authors:  E Bourreau; C Ronet; E Darcissac; M C Lise; D Sainte Marie; E Clity; F Tacchini-Cottier; P Couppie; P Launois
Journal:  Infect Immun       Date:  2009-01-21       Impact factor: 3.441

8.  Transplant tolerance to pancreatic islets is initiated in the graft and sustained in the spleen.

Authors:  N Gagliani; T Jofra; A Valle; A Stabilini; C Morsiani; S Gregori; S Deng; D M Rothstein; M Atkinson; M Kamanaka; R A Flavell; M G Roncarolo; M Battaglia
Journal:  Am J Transplant       Date:  2013-07-08       Impact factor: 8.086

9.  Regulatory T-cell profile in early and late lesions of cutaneous leishmaniasis due to Leishmania major.

Authors:  Shervin G Hoseini; Shaghayegh H Javanmard; Sayyed H Zarkesh; Ali Khamesipour; Laleh Rafiei; Khadijeh Karbalaie; Mohamadali Nilforoushzade; Mehdi Baghaei; Seyed H Hejazi
Journal:  J Res Med Sci       Date:  2012-06       Impact factor: 1.852

Review 10.  Natural killer cells in experimental and human leishmaniasis.

Authors:  Christian Bogdan
Journal:  Front Cell Infect Microbiol       Date:  2012-05-29       Impact factor: 5.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.